ImmunoGen, Inc.: capex
| Value | {"amount": 5249000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-06-30 |
| Status | current |
| Entity | ImmunoGen, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f2bc509c-1e2c-40f2-9220-a056b2a044cf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-17-005987 · Open the official SEC filing →Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000855654/capex/2016-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f2bc509c-1e2c-40f2-9220-a056b2a044cf
History
- no predecessors — first report